SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-09-048402
Filing Date
2009-09-15
Accepted
2009-09-14 19:42:31
Documents
10
Period of Report
2009-09-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v160374_8k.htm 8-K 51927
2 v160374_ex1-1.htm EX-1.1 124887
3 GRAPHIC logo.jpg GRAPHIC 20898
4 v160374_ex1-2.htm EX-1.2 113600
5 GRAPHIC logo1.jpg GRAPHIC 14122
6 GRAPHIC logo2.jpg GRAPHIC 6226
7 v160374_ex4-1.htm EX-4.1 117932
8 v160374_ex4-2.htm EX-4.2 103215
9 v160374_ex10-1.htm EX-10.1 204638
10 v160374_ex99-1.htm EX-99.1 14241
  Complete submission text file 0001144204-09-048402.txt   789225
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 091068594
SIC: 2834 Pharmaceutical Preparations